Rescheduling – Powering the Brain: A Parent’s Guide to Mitochondria and ASD with Sundeep Dugar, PhD

Join host Wendy Fournier for a conversation with Dr. Sundeep Dugar, co-founder and Chief Scientific Officer of Blue Oak Nutraceuticals, on the importance of mitochondrial function in individuals with ASD. Together, they will examine how focus, mood, development, immune function, and overall well-being are directly tied to cellular energy. By attending this session, attendees will leave with a deeper understanding of mitochondria – the biological engines driving their child’s development. What you can expect to learn:

• • Impact of internal cellular energy on external behaviors
  • Why mitochondria are at the center of health
  • Definitions of the Bioenergetic Threshold and Cell Danger Response (CDR)
  • Shifting from defense mode to growth mode
  • How to proactively build a foundation for health and resilience

Sundeep has almost 40 years of experience and great success in small-molecule drug discovery and development in oncology, – inflammation,
 the central nervous system, and cardiovascular and metabolic disorders. Founded Advantium Pharma (2005), a contract research and manufacturing company; Sphaera Pharma (2008), establishing a new and unique model for drug discovery and development; Epirium Bio (2019), a clinical-stage biopharmaceutical company; Aayam Therapeutics (2022) advancing therapeutics for patients. Sundeep has almost 40 years of experience and great success in small-molecule drug discovery and development in oncology, – inflammation,
 the central nervous system, and cardiovascular and metabolic disorders. Founded Advantium Pharma (2005), a contract research and manufacturing company; Sphaera Pharma (2008), establishing a new and unique model for drug discovery and development; Epirium Bio (2019), a clinical-stage biopharmaceutical company; Aayam Therapeutics (2022) advancing therapeutics for patients. 15 years ago, research in mitochondrial bioenergetics piqued his interest, and he has devoted significant time and resources to this research ever since.

• • Co-inventor of Zetia® (ezetimibe) and Vytorin®(ezetimibe/simvastatin) at Bristol-Myers Squibb and Schering-Plough. American Chemical Society’s 2005 National Inventor of the Year Award and 2004 Heroes of Chemistry Award.
  • Co-author of 70+ publications and presentations, and co-inventor on 100+ issued and applied patents.
  • Co-organizer of the R. Bryan Miller Symposium at UC Davis for 20+ years, where he is Senior Research Fellow, helped create the UC Davis Pharmaceutical Chemistry program, and previously served as Trustee of the UC Davis Foundation.
  • Leading team (named A New Dimension) that is a semifinalist and Top 40 Milestone 1 Award winner in the prestigious $101 Million XPRIZE Healthspan competition.
  • Post-doctoral fellowship – Swiss Federal Institute of Technology (ETH)
  • Post-doctoral fellowship – Cornell University Ph.D. Chemistry – University of California Davis